More Options For Opioid Overdose: Nasal Naloxone On Brink Of OTC Use, While Opiant And Orexo Stay Rx To Counter High-Potency Opioids

 
• By Bridget Silverman
  
User fee goals are approaching for several proposed naloxone products. • Source: Shutterstock

More from R&D

More from Pink Sheet